Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (937)	12/8/2005 12:01:45 PM
From: richardred	Read Replies (3) \| Respond to of 7243

ARRO-new buy today-Possible target- Arrow International, Inc.-Reinvested BNT proceeds. Indirect play-Stock closely held, but anything goes for the right price. Medical devices, IMO to hot a market to ignore in the takeover speculation game. Even better profit margins than DSCP.

To: richardred who wrote (937)	12/9/2005 12:30:38 AM
From: richardred	Read Replies (1) \| Respond to of 7243

I guess this evens things out a bit! Datascope delays launch of vascular closure device Thu Dec 8, 2005 06:14 PM ET LOS ANGELES, Dec 8 (Reuters) - Medical device company Datascope Corp. (DSCP.O: Quote, Profile, Research) on Thursday said it delayed the launch of its X-Site vascular closure device until the first quarter of fiscal 2007. The company said market feedback revealed a preference for a pre-tied knot as an "integral part of the device," rather than the suture knot-tier as an accessory as the product currently provides. yahoo.reuters.com